Risk of Wernicke's encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm

Cancer Epidemiology
Jasmanda WuJuhaeri Juhaeri

Abstract

The objectives of the study were to estimate the incidence of Wernicke's encephalopathy (WE) and cardiac disorders among patients with myeloproliferative neoplasms (MPN), and compare it with those without MPN. A total of 39,761 MPN patients were identified from the US Marketscan database. Approximately 27% of them were 65+ years of age, and 51% were male. Patients with MPN had higher rates of WE, compared to those without MPN (MPN vs. non-MPN: 1.09 vs. 0.39/1000 person-year, adjusted HR=2.19, 95%CI 1.43-3.34). Patients with MPN also had higher rates of cardiac events (congestive heart failure: MPN vs. non-MPN: 9.27 vs. 3.70/1000 person-year, adjusted HR=1.64, 95%CI 1.42-1.88; acute myocardial infarction: MPN vs. non-MPN: 10.45 vs. 5.02/1000 person-year, adjusted HR=1.44, 95%CI 1.27, 1.63; cardiac arrhythmia: MPN vs. non-MPN: 106.5 vs. 53.9/1000 person-year, adjusted HR=1.42, 95%CI 1.36-1.48). Physicians who care for patients with MPN should be aware of increased risk of WE and cardiac disorders in this population.

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Aug 10, 2000·Public Health Nutrition·S Rolland, A S Truswell
Feb 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roberto MarchioliTiziano Barbui
Nov 24, 2005·Hematology·Peter J Campbell, Anthony R Green
Oct 5, 2006·Cancer·Barbara Deschler, Michael Lübbert
Dec 8, 2009·Blood·Tiziano BarbuiGiovanni Barosi
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayalew Tefferi, William Vainchenker
Dec 12, 2013·The New England Journal of Medicine·J NangaliaA R Green
Dec 29, 2013·Blood·Giada RotunnoUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators

❮ Previous
Next ❯

Citations

Nov 3, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marilyn M GiacominiAdrian S Ray
Aug 10, 2018·Clinical Pharmacology and Therapeutics·Maciej J Zamek-GliszczynskiUNKNOWN International Transporter Consortium
Jun 2, 2020·Therapeutic Advances in Hematology·Jeanne Palmer, Ruben Mesa
Aug 30, 2017·Expert Opinion on Drug Metabolism & Toxicology·Eve-Irene Lepist, Adrian S Ray
Aug 31, 2021·OncoTargets and Therapy·Julian A WaksalJohn Mascarenhas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Ugeskrift for laeger
A Schapira
Lancet
Markus Ploner, Alfons Schnitzler
Treatment Services Bulletin
K W G BROWN
© 2022 Meta ULC. All rights reserved